NEUROBLASTOMA
Clinical trials for NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells take on childhood cancer in new trial
Disease control OngoingThis early-phase trial tests a new treatment for children with neuroblastoma that has come back or not responded to standard therapy. It uses the child's own natural killer (NK) cells, grown in a lab, combined with an antibody drug (dinutuximab) and sometimes another drug (lenali…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Apr 29, 2026 01:35 UTC
-
Could a 4-Hour infusion replace 20-Hour hospital stays for kids with neuroblastoma?
Symptom relief OngoingThis study tests whether giving the drug dinutuximab over 4 hours or less is safe and doable for children with high-risk neuroblastoma. Currently, the standard infusion takes 10-20 hours and requires a hospital stay. The goal is to see if a faster infusion can be given in an outp…
Matched conditions: NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Children's Hospital Los Angeles • Aim: Symptom relief
Last updated Apr 29, 2026 01:37 UTC